0001752724-24-010259.txt : 20240124
0001752724-24-010259.hdr.sgml : 20240124
20240124132254
ACCESSION NUMBER: 0001752724-24-010259
CONFORMED SUBMISSION TYPE: NPORT-P
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
PERIOD START: 20240229
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BNY Mellon ETF Trust
CENTRAL INDEX KEY: 0001493580
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FILING VALUES:
FORM TYPE: NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-23477
FILM NUMBER: 24555540
BUSINESS ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
BUSINESS PHONE: 212-922-6400
MAIL ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
FORMER COMPANY:
FORMER CONFORMED NAME: Dreyfus ETF Trust
DATE OF NAME CHANGE: 20100607
0001493580
S000080184
BNY Mellon Women's Opportunities ETF
C000241888
BNY Mellon Women's Opportunities ETF
BKWO
NPORT-P
1
primary_doc.xml
NPORT-P
false
0001493580
XXXXXXXX
S000080184
C000241888
BNY Mellon ETF Trust
811-23477
0001493580
549300E2C8EQYJ7B0H81
240 Greenwich Street
New York
10286
212-922-6400
BNY Mellon Womens Opportunities ETF
S000080184
549300QAQYJD1TI1DO07
2024-02-29
2023-11-30
N
10863535.30
4304.47
10859230.83
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
Akamai Technologies Inc
OC1LZNN2LF5WTJ5RIL89
Akamai Technologies Inc
00971T101
1517.00000000
NS
USD
175259.01000000
1.613917345930
Long
EC
CORP
US
N
1
N
N
N
Alnylam Pharmaceuticals Inc
529900S3ZI14OWRJII50
Alnylam Pharmaceuticals Inc
02043Q107
480.00000000
NS
USD
80760.00000000
0.743699082046
Long
EC
CORP
US
N
1
N
N
N
Eli Lilly & Co
FRDRIPF3EKNDJ2CQJL29
Eli Lilly & Co
532457108
544.00000000
NS
USD
321525.76000000
2.960852062484
Long
EC
CORP
US
N
1
N
N
N
Danaher Corp
S4BKK9OTCEWQ3YHPFM11
Danaher Corp
235851102
992.00000000
NS
USD
221523.52000000
2.039955899896
Long
EC
CORP
US
N
1
N
N
N
NVIDIA Corp
549300S4KLFTLO7GSQ80
NVIDIA Corp
67066G104
780.00000000
NS
USD
364806.00000000
3.359409204123
Long
EC
CORP
US
N
1
N
N
N
Centene Corp
549300Z7JJ4TQSQGT333
Centene Corp
15135B101
2400.00000000
NS
USD
176832.00000000
1.628402626008
Long
EC
CORP
US
N
1
N
N
N
HubSpot Inc
529900BLNVEW0MVKJB37
HubSpot Inc
443573100
470.00000000
NS
USD
232147.10000000
2.137785849055
Long
EC
CORP
US
N
1
N
N
N
Hologic Inc
549300DYP6F5ZJL0LB74
Hologic Inc
436440101
1816.00000000
NS
USD
129480.80000000
1.192357009690
Long
EC
CORP
US
N
1
N
N
N
AbbVie Inc
FR5LCKFTG8054YNNRU85
AbbVie Inc
00287Y109
2248.00000000
NS
USD
320092.72000000
2.947655547718
Long
EC
CORP
US
N
1
N
N
N
Progyny Inc
N/A
Progyny Inc
74340E103
5520.00000000
NS
USD
189667.20000000
1.746598842673
Long
EC
CORP
US
N
1
N
N
N
Zoetis Inc
549300HD9Q1LOC9KLJ48
Zoetis Inc
98978V103
570.00000000
NS
USD
100701.90000000
0.927339160355
Long
EC
CORP
US
N
1
N
N
N
Procter & Gamble Co/The
2572IBTT8CCZW6AU4141
Procter & Gamble Co/The
742718109
1165.00000000
NS
USD
178850.80000000
1.646993261308
Long
EC
CORP
US
N
1
N
N
N
JPMorgan Chase & Co
8I5DZWZKVSZI1NUHU748
JPMorgan Chase & Co
46625H100
2416.00000000
NS
USD
377089.28000000
3.472522924535
Long
EC
CORP
US
N
1
N
N
N
Schlumberger NV
213800ZUA17OK3QLGM62
Schlumberger NV
806857108
3384.00000000
NS
USD
176103.36000000
1.621692758510
Long
EC
CORP
US
N
1
N
N
N
Mastercard Inc
AR5L2ODV9HN37376R084
Mastercard Inc
57636Q104
784.00000000
NS
USD
324442.72000000
2.987713633489
Long
EC
CORP
US
N
1
N
N
N
PepsiCo Inc
FJSUNZKFNQ5YPJ5OT455
PepsiCo Inc
713448108
1288.00000000
NS
USD
216757.52000000
1.996066971899
Long
EC
CORP
US
N
1
N
N
N
Cooper Cos Inc/The
QJKMVPIGLH7530PCUE20
Cooper Cos Inc/The
216648402
413.00000000
NS
USD
139147.96000000
1.281379521057
Long
EC
CORP
US
N
1
N
N
N
Exelon Corp
3SOUA6IRML7435B56G12
Exelon Corp
30161N101
4896.00000000
NS
USD
188544.96000000
1.736264409069
Long
EC
CORP
US
N
1
N
N
N
Bright Horizons Family Solutio
N/A
Bright Horizons Family Solutions Inc
109194100
2826.00000000
NS
USD
247105.44000000
2.275533542553
Long
EC
CORP
US
N
1
N
N
N
Dreyfus Institutional Preferred Government Money Market Fund
549300RBWL04JG8SIX57
Dreyfus Institutional Preferred Government Money Market Fund
000000000
162893.64000000
NS
USD
162893.64000000
1.500047678791
Long
STIV
RF
US
N
1
N
N
N
Boston Scientific Corp
Y6ZDD9FP4P8JSSJMW954
Boston Scientific Corp
101137107
4676.00000000
NS
USD
261341.64000000
2.406631225464
Long
EC
CORP
US
N
1
N
N
N
Caterpillar Inc
WRJR7GS4GTRECRRTVX92
Caterpillar Inc
149123101
420.00000000
NS
USD
105302.40000000
0.969704039342
Long
EC
CORP
US
N
1
N
N
N
Shopify Inc
549300HGQ43STJLLP808
Shopify Inc
82509L107
4488.00000000
NS
USD
326816.16000000
3.009570061786
Long
EC
CORP
CA
N
1
N
N
N
Omnicom Group Inc
HKUPACFHSSASQK8HLS17
Omnicom Group Inc
681919106
1714.00000000
NS
USD
138199.82000000
1.272648331760
Long
EC
CORP
US
N
1
N
N
N
Bank of America Corp
9DJT3UXIJIZJI4WXO774
Bank of America Corp
060505104
3648.00000000
NS
USD
111227.52000000
1.024267019840
Long
EC
CORP
US
N
1
N
N
N
Workday Inc
549300J0DYC0N31V7G13
Workday Inc
98138H101
720.00000000
NS
USD
194918.40000000
1.794955858765
Long
EC
CORP
US
N
1
N
N
N
Applied Materials Inc
41BNNE1AFPNAZELZ6K07
Applied Materials Inc
038222105
1335.00000000
NS
USD
199956.30000000
1.841348647342
Long
EC
CORP
US
N
1
N
N
N
Illumina Inc
SQ95QG8SR5Q56LSNF682
Illumina Inc
452327109
1352.00000000
NS
USD
137836.40000000
1.269301685891
Long
EC
CORP
US
N
1
N
N
N
Lululemon Athletica Inc
549300D9GZ4BMLDW5T40
Lululemon Athletica Inc
550021109
536.00000000
NS
USD
239484.80000000
2.205356933185
Long
EC
CORP
CA
N
1
N
N
N
Progressive Corp/The
529900TACNVLY9DCR586
Progressive Corp/The
743315103
1888.00000000
NS
USD
309688.64000000
2.851846920358
Long
EC
CORP
US
N
1
N
N
N
CoStar Group Inc
N/A
CoStar Group Inc
22160N109
1779.00000000
NS
USD
147728.16000000
1.360392483709
Long
EC
CORP
US
N
1
N
N
N
Alcoa Corp
549300T12EZ1F6PWWU29
Alcoa Corp
013872106
3318.00000000
NS
USD
89121.48000000
0.820697905728
Long
EC
CORP
US
N
1
N
N
N
Intuit Inc
VI90HBPH7XSFMB9E4M29
Intuit Inc
461202103
496.00000000
NS
USD
283444.16000000
2.610167924757
Long
EC
CORP
US
N
1
N
N
N
FedEx Corp
549300E707U7WNPZN687
FedEx Corp
31428X106
1104.00000000
NS
USD
285748.32000000
2.631386370483
Long
EC
CORP
US
N
1
N
N
N
Walt Disney Co/The
549300GZKULIZ0WOW665
Walt Disney Co/The
254687106
1248.00000000
NS
USD
115677.12000000
1.065242297644
Long
EC
CORP
US
N
1
N
N
N
Meta Platforms Inc
BQ4BKCS1HXDV9HN80Z93
Meta Platforms Inc
30303M102
806.00000000
NS
USD
263682.90000000
2.428191316014
Long
EC
CORP
US
N
1
N
N
N
Constellium SE
724500KRJEMC79KAAU28
Constellium SE
000000000
5856.00000000
NS
USD
101894.40000000
0.938320601110
Long
EC
CORP
FR
N
1
N
N
N
Accenture PLC
5493000EWHDSR3MZWH98
Accenture PLC
000000000
761.00000000
NS
USD
253519.54000000
2.334599420242
Long
EC
CORP
IE
N
1
N
N
N
Trane Technologies PLC
549300BURLR9SLYY2705
Trane Technologies PLC
000000000
848.00000000
NS
USD
191147.68000000
1.760232220793
Long
EC
CORP
IE
N
1
N
N
N
Veralto Corp
635400FJE6GSOJUSNY27
Veralto Corp
92338C103
1031.00000000
NS
USD
79644.75000000
0.733429017642
Long
EC
CORP
US
N
1
N
N
N
Amazon.com Inc
ZXTILKJKG63JELOEG630
Amazon.com Inc
023135106
4280.00000000
NS
USD
625265.20000000
5.757914255516
Long
EC
CORP
US
N
1
N
N
N
Uber Technologies Inc
549300B2FTG34FILDR98
Uber Technologies Inc
90353T100
6040.00000000
NS
USD
340535.20000000
3.135905344780
Long
EC
CORP
US
N
1
N
N
N
Texas Instruments Inc
WDJNR2L6D8RWOEB8T652
Texas Instruments Inc
882508104
756.00000000
NS
USD
115448.76000000
1.063139386272
Long
EC
CORP
US
N
1
N
N
N
ConocoPhillips
WPTL2Z3FIYTHSP5V2253
ConocoPhillips
20825C104
1012.00000000
NS
USD
116956.84000000
1.077026926040
Long
EC
CORP
US
N
1
N
N
N
Block Inc
549300OHIIUWSTIZME52
Block Inc
852234103
1784.00000000
NS
USD
113159.12000000
1.042054651673
Long
EC
CORP
US
N
1
N
N
N
Addus HomeCare Corp
52990090ZT33AKPDBX62
Addus HomeCare Corp
006739106
1152.00000000
NS
USD
100454.40000000
0.925059993406
Long
EC
CORP
US
N
1
N
N
N
Occidental Petroleum Corp
IM7X0T3ECJW4C1T7ON55
Occidental Petroleum Corp
674599105
2773.00000000
NS
USD
164022.95000000
1.510447218295
Long
EC
CORP
US
N
1
N
N
N
ANSYS Inc
549300VJV8H15Z5FJ571
ANSYS Inc
03662Q105
588.00000000
NS
USD
172495.68000000
1.588470516009
Long
EC
CORP
US
N
1
N
N
N
Microsoft Corp
INR2EJN1ERAN0W5ZP974
Microsoft Corp
594918104
2496.00000000
NS
USD
945759.36000000
8.709266565982
Long
EC
CORP
US
N
1
N
N
N
2024-01-17
BNY Mellon ETF Trust
James Windels
James Windels
Treasurer
XXXX
NPORT-EX
2
647974BNYM113023.htm
STATEMENT
OF
INVESTMENTS
November
30,
2023
(Unaudited)
Description
Shares
Value
($)
Common
Stocks
–
98.5%
Banks
–
4.5%
Bank
of
America
Corp.
3,648
111,228
JPMorgan
Chase
&
Co.
2,416
377,089
488,317
Capital
Goods
–
2.7%
Caterpillar,
Inc.
420
105,302
Trane
Technologies
PLC
848
191,148
296,450
Commercial
&
Professional
Services
–
0.7%
Veralto
Corp.
(a)
1,031
79,645
Consumer
Discretionary
Distribution
&
Retail
–
5.8%
Amazon.com,
Inc.
(a)
4,280
625,265
Consumer
Durables
&
Apparel
–
2.2%
Lululemon
Athletica,
Inc.
(a)
536
239,485
Consumer
Services
–
2.3%
Bright
Horizons
Family
Solutions,
Inc.
(a)
2,826
247,105
Energy
–
4.2%
ConocoPhillips
1,012
116,957
Occidental
Petroleum
Corp.
2,773
164,023
Schlumberger
NV
3,384
176,103
457,083
Financial
Services
–
4.0%
Block,
Inc.
(a)
1,784
113,159
Mastercard,
Inc.,
Class
A
784
324,443
437,602
Food,
Beverage
&
Tobacco
–
2.0%
PepsiCo,
Inc.
1,288
216,758
Health
Care
Equipment
&
Services
–
9.2%
Addus
Homecare
Corp.
(a)
1,152
100,454
Boston
Scientific
Corp.
(a)
4,676
261,342
Centene
Corp.
(a)
2,400
176,832
Cooper
Cos.,
Inc.
(The)
413
139,148
Hologic,
Inc.
(a)
1,816
129,481
Progyny,
Inc.
(a)
5,520
189,667
996,924
Household
&
Personal
Products
–
1.6%
Procter
&
Gamble
Co.
(The)
1,165
178,851
STATEMENT
OF
INVESTMENTS
(continued)
Description
Shares
Value
($)
Common
Stocks
–
98.5%
(continued)
Insurance
–
2.8%
Progressive
Corp.
(The)
1,888
309,689
Materials
–
1.8%
Alcoa
Corp.
3,318
89,122
Constellium
SE
(a)
5,856
101,894
191,016
Media
&
Entertainment
–
4.8%
Meta
Platforms,
Inc.,
Class
A
(a)
806
263,683
Omnicom
Group,
Inc.
1,714
138,200
Walt
Disney
Co.
(The)
(a)
1,248
115,677
517,560
Pharmaceuticals,
Biotechnology
&
Life
Sciences
–
10.9%
AbbVie,
Inc.
2,248
320,093
Alnylam
Pharmaceuticals,
Inc.
(a)
480
80,760
Danaher
Corp.
992
221,523
Eli
Lilly
&
Co.
544
321,526
Illumina,
Inc.
(a)
1,352
137,836
Zoetis,
Inc.
570
100,702
1,182,440
Real
Estate
Management
&
Development
–
1.4%
CoStar
Group,
Inc.
(a)
1,779
147,728
Semiconductors
&
Semiconductor
Equipment
–
6.3%
Applied
Materials,
Inc.
1,335
199,956
NVIDIA
Corp.
780
364,806
Texas
Instruments,
Inc.
756
115,449
680,211
Software
&
Services
–
23.8%
Accenture
PLC,
Class
A
761
253,520
Akamai
Technologies,
Inc.
(a)
1,517
175,259
ANSYS,
Inc.
(a)
588
172,496
HubSpot,
Inc.
(a)
470
232,147
Intuit,
Inc.
496
283,444
Microsoft
Corp.
2,496
945,759
Shopify,
Inc.,
Class
A
(a)
4,488
326,816
Workday,
Inc.,
Class
A
(a)
720
194,918
2,584,359
Transportation
–
5.8%
FedEx
Corp.
1,104
285,748
Uber
Technologies,
Inc.
(a)
6,040
340,535
626,283
Utilities
–
1.7%
Exelon
Corp.
4,896
188,545
Total
Common
Stocks
(cost
$9,717,886)
10,691,316
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Investment
Companies
–
1.5%
Registered
Investment
Companies
–
1.5%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.32%
(b)(c)
(cost
$162,894)
162,894
162,894
Total
Investments
(cost
$9,880,780)
100.0%
10,854,210
Cash
and
Receivables
(Net)
0.0%
5,021
Net
Assets
100.0%
10,859,231
(a)
Non-income
producing
security.
(b)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(c)
The
rate
shown
is
the
1-day
yield
as
of
November
30,
2023.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Women's
Opportunities
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
—
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
—
other
significant
observable
inputs
(including
quoted
prices
for
similar
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
—
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies),
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy.
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
The
table
below
summarizes
the
inputs
used
as
of November
30,
2023
in
valuing
the
fund’s
investments:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
Fair
Value
Measurements
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
semi-annual
report
previously
filed
with
the
SEC
on
Form
N-CSR.
At November
30,
2023,
accumulated
net
unrealized
appreciation on
investments
was
$973,430,
consisting
of
gross
appreciation
of
$1,282,809
and
gross
depreciation
of
$309,379.
At
November
30,
2023,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
†
Common
Stocks
10,691,316
—
—
10,691,316
Investment
Companies
162,894
—
—
162,894
†
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.